GekoTM: a new revolution in DVT prophylaxis?
Deep vein thrombosis (DVT) is the formation of coagulated blood in one of the deep venous systems of the lower limbs, which is usually instigated by venous stasis, already-present endothelial damage of the veins and a predisposition to hypercoagulability. Despite the many advances in pharmacological prophylaxis for post-surgical DVT, it still remains a highly prevalent problem with an annual incidence of 80 cases per 100,000 and up to 50% causing life-threatening pulmonary embolism (PE)[1]. Furthermore, with the use of pharmacological prophylaxis, there is a need to balance out immediate post-surgical haemorrhage with the formation of DVT.
Read More